SCHEMBL845682

SCHEMBL845682

O=C(Nc1ccc(/C=C/c2ccc(NC(=O)[C@@H]3CCCN3C(=O)c3ccccc3NCc3ccccc3)cc2)cc1)[C@@H]1CCCN1C(=O)c1ccccc1NCc1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.54
MEN1 O00255 1/20 0.48
KMT2A Q03164 1/20 0.48
USP2 O75604 1/20 0.47
KDM4E B2RXH2 1/20 0.46
LMNA P02545 1/20 0.46
HSD17B10 Q99714 1/20 0.45
NPC1 O15118 1/20 0.45
CYP2C9 P11712 1/20 0.45
CYP2C19 P33261 1/20 0.45
KDM1A O60341 1/20 0.44
RCOR1 Q9UKL0 1/20 0.44
GAA P10253 1/20 0.44
PABPC1 P11940 1/20 0.43
MAPK1 P28482 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL845371 0.95 ALDH1A1 (0.52) ALDH1A1MEN1KMT2AUSP2KDM4E
SCHEMBL845027 0.93 ALDH1A1 (0.48) ALDH1A1MEN1KMT2AUSP2KDM4E
SCHEMBL874311 0.92 ALDH1A1 (0.47) ALDH1A1MEN1KMT2AUSP2KDM4E
SCHEMBL845376 0.89 ALDH1A1 (0.44) ALDH1A1MEN1KMT2AUSP2KDM4E
SCHEMBL845189 0.87 ALDH1A1 (0.49) ALDH1A1MEN1KMT2AUSP2KDM4E
SCHEMBL13272423 0.87 GAA (0.43) ALDH1A1MEN1KMT2AKDM4ELMNA
SCHEMBL845337 0.86 GAA (0.45) ALDH1A1KDM4ELMNANPC1CYP2C9
SCHEMBL845043 0.86 ALDH1A1 (0.47) ALDH1A1LMNAHSD17B10CYP2C9CYP2C19
SCHEMBL845350 0.85 MAPK1 (0.49) ALDH1A1LMNACYP2C9CYP2C19GAA
SCHEMBL845392 0.84 ALDH1A1 (0.51) ALDH1A1MEN1KMT2AUSP2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed
EP-1893573-B1 INHIBITORS OF HCV REPLICATION BRISTOL MYERS SQUIBB CO (US) 2010-07-21 EP disclosed